Immunotherapeutic effects of Glycyrrhiza glabra and Glycyrrhizic Acid on Leishmania major-infection BALB/C mice.

Publisher: Wiley Country of Publication: England NLM ID: 7910948 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-3024 (Electronic) Linking ISSN: 01419838 NLM ISO Abbreviation: Parasite Immunol Subsets: MEDLINE

Original Publication: Oxford, Wiley

Antiprotozoal Agents*/pharmacology ; Glycyrrhiza* ; Leishmania major* ; Leishmaniasis, Cutaneous*/drug therapy; Animals ; Glycyrrhizic Acid/pharmacology ; Glycyrrhizic Acid/therapeutic use ; Immunotherapy ; Mice ; Mice, Inbred BALB C

Treatment of cutaneous leishmaniasis (CL) is a public health problem in endemic areas. The objective of the current study was to investigate the immunotherapeutic activities of the hydroalcoholic extract of Glycyrrhiza glabra (HEG) and glycyrrhizic acid (GA) in the treatment of Leishmania major (L. major)-infected BALB/c mice. In this study, the effect of HEG and GA was checked in vitro on growth of L. major promastigote and amastigote using MTT assay and microscopic counting, respectively. For in vivo experiment, the lesion induced by L. major on BALB/c mice were treated intraperitoneally with HEG, GA, meglumine antimoniate or phosphate buffer saline (negative control) for one month. Then, the lesion development and the parasite burden of the lymph node was assessed, the cytokine response (IFN-γ and IL-4) to Leishmania antigens was evaluated using ELISA method. The results showed that HEG and GA significantly inhibited the growth of L. major promastigotes and amastigotes, the lesion development, parasite burden in the lymph nodes, level of IFN-γ and the ratio of IFN-γ/IL-4 in HEG, GA and meglumine antimoniate-treated mice were significantly higher compared with the negative control group, there was no difference between the HEG, GA and meglumine antimoniate group. It is concluded that hydroalcoholic extract of G. glabra and glycyrrhizic acid showed therapeutic and immunomodulatory effects on L. major-infected BALB/c mice.
(© 2021 John Wiley & Sons Ltd.)

Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671.
Organization WH Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, Switzerland. WHO technical report series. 2010;(949):22-26.
Gollob KJ, Viana AG, Dutra WO. Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunol. 2014;36(8):367-376.
Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: A review. F1000Res. 2017;6:750.
Louis J, Himmelrich H, Parra-Lopez C, Tacchini-Cottier F, Launois P. Regulation of protective immunity against Leishmania major in mice. Curr Opin Immunol. 1998;10(4):459-464.
Heinzel FP, Sadick MD, Mutha SS, Locksley RM. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci. 1991;88(16):7011-7015.
Carrion J, Nieto A, Iborra S, et al. Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol. 2006;28(5):173-183.
Afonso L, Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun. 1993;61(7):2952-2959.
Moreira VR, de Jesus LCL, Soares R-EP, et al. Meglumine antimoniate (Glucantime) causes oxidative stress-derived DNA damage in BALB/c mice infected by Leishmania (Leishmania) infantum. Antimicrob Agents Chemother. 2017;61(6):e02360-e2416.
Mohammadzadeh M, Behnaz F, Golshan Z. Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran. Journal of Infection and Public Health. 2013;6(2):120-124.
Sundar S, Chakravarty J. Leishmaniasis: an update of current pharmacotherapy. Expert Opin Pharmacother. 2013;14(1):53-63.
Oliveira LF, Schubach AO, Martins MM, et al. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop. 2011;118(2):87-96.
Monge-Maillo B, López-Vélez R. Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis. Drugs. 2013;73(17):1889-1920.
Monzote L. Current treatment of leishmaniasis: a review. The Open Antimicrobial Agents Journal. 2009;1(1).
Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG. Case study for a vaccine against leishmaniasis. Vaccine. 2013;31:B244-B249.
Noazin S, Khamesipour A, Tanner M, Nasseri K, Modabber F, et al. Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis-A meta-analysis. Vaccine. 2009;27(35):4747-4753.
Ganguly S, Prasad A. Role of plant extracts and cow urine distillate as immunomodulator in comparison to Levamisole-A Review. J of Immunol and Immunopathol. 2010;12(2):91-94.
Chouhan G, Islamuddin M, Sahal D, Afrin F. Exploring the role of medicinal plant-based immunomodulators for effective therapy of leishmaniasis. Front Immunol. 2014;5:193.
Singh N, Mishra BB, Bajpai S, Singh RK, Tiwari VK. Natural product based leads to fight against leishmaniasis. Bioorg Med Chem. 2014;22(1):18-45.
Asnaashari S, Dastmalchi S, Javadzadeh Y. Gastroprotective effects of herbal medicines (roots). Int J Food Prop. 2018;21(1):902-920.
Dissanayake K, Weerakoon W, Perera W. Root/Stem Extracts of Glycyrrhiza glabra; As a Medicinal Plant Against Disease Forming Microorganisms. Int J of Sci Basic and Applied Rese. 2020;1-11.
Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira MBP. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother Res. 2018;32(12):2323-2339.
El-Saber Batiha G, Magdy Beshbishy A, El-Mleeh A, Abdel-Daim M. Traditional uses, bioactive chemical constituents, and pharmacological and toxicological activities of Glycyrrhiza glabra L. (Fabaceae). Biomolecules. 2020;10(3):352.
Richard SA. Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids. Mediators Inflamm. 2021;2021.
Damle M. Glycyrrhiza glabra (Liquorice)-a potent medicinal herb. International Journal of Herbal Medicine. 2014;2(2):132-136.
Kaur R, Kaur H, Dhindsa AS. Glycyrrhiza glabra: a phytopharmacological review. Int J of Pharma Sci and Res. 2013;4(7):2470.
Chauhan S, Gulati N, Nagaich U. Glycyrrhizic acid: extraction, screening and evaluation of anti-inflammatory property. Ars Pharm. 2018;59(2):61-67.
Nezamabadi N, Rahimian MH, Zand E. Investigation of some ecophysiological aspects of licorice (Glycyrrhiza glabra) rhizomes. Appled Entomol And Phytopatpl. 2007;74(282):45-61.
Tian M, Yan H, Row KH. Extraction of glycyrrhizic acid and glabridin from licorice. Int J Mol Sci. 2008;9(4):571-577.
Hennell JR, Lee S, Khoo C, Gray MJ, Bensoussan A. The determination of glycyrrhizic acid in Glycyrrhiza uralensis Fisch. ex DC. (Zhi Gan Cao) root and the dried aqueous extract by LC-DAD. J Pharm Biomed Anal. 2008;47(3):494-500.
Husain A, Ahmad A, Mujeeb M, Khan S, Alghamdi A, Anwar F. Quantitative analysis of total phenolic, flavonoid contents and HPTLC fingerprinting for standardization of Glycyrrhiza glabra Linn. Root Herb Med. 2015;2(1):1-9.
Ammosov A, Litvinenko V. Triterpenoids of Plants of Glycyrrhiza L. and Meristotropis Fisch. Et Mey Genuses (A REVIEW). Pharm Chem J. 2003;37(2):83-94.
Saxena S. Glycyrrhiza glabra: medicine over the millennium. Natural Product Radiance. 2005;4(5):358-367.
Shah SL, Wahid F, Khan N, et al. Inhibitory effects of Glycyrrhiza glabra and its major constituent glycyrrhizin on inflammation-associated corneal neovascularization. Evidence-Based Complementary and Alternative Medicine. 2018;2018.
Varsha S, Agrawal R, Sonam P. Phytochemical screening and determination of anti-bacterial and anti-oxidant potential of Glycyrrhiza glabra root extracts. J. Environ. Res. Develop. 2013;7(4A):1552.
Pompei R, Flore O, Marccialis MA, Pani A, Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature. 1979;281(5733):689.
Sheela M, Ramakrishna M, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol. 2006;6(3):494-498.
Bordbar N, Karimi MH, Amirghofran Z. The effect of glycyrrhizin on maturation and T cell stimulating activity of dendritic cells. Cell Immunol. 2012;280(1):44-49.
Hosseinzadeh H, Nassiri-Asl M. Pharmacological effects of Glycyrrhiza spp. and its bioactive constituents: update and review. Phytother Res. 2015;29(12):1868-1886.
Rahal A, Deb R, Latheef SK, et al. Immunomodulatory and therapeutic potentials of herbal, traditional/indigenous and ethnoveterinary medicines. Pakistan Journal of Biological Sciences: PJBS. 2012;15(16):754-774.
Bhattacharjee A, Majumder S, Majumdar SB, Choudhuri SK, Roy S, Majumdar S. Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis. Int J Antimicrob Agents. 2015;45(3):268-277.
Bhattacharjee S, Bhattacharjee A, Majumder S, Majumdar SB, Majumdar S. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection. J Antimicrob Chemother. 2012;67(8):1905-1914.
Mazumder PM, Pattnayak S, Parvani H, Sasmal D, Rathinavelusamy P. Evaluation of immunomodulatory activity of Glycyrhiza glabra L roots in combination with zing. Asian Pacific J of Trop Biomed. 2012;2(1):15-20.
Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res. 2008;22(6):709-724.
Cheel J, Van Antwerpen P, Tumava L, et al. Free radical-scavenging, antioxidant and immunostimulating effects of a licorice infusion (Glycyrrhiza glabra L.). Food Chem. 2010;122(3):508-517.
Cheng A, Wan F, Wang J, Jin Z, Xu X. Macrophage immunomodulatory activity of polysaccharides isolated from Glycyrrhiza uralensis fish. Int Immunopharmacol. 2008;8(1):43-50.
Kim J, Joo I, Kim H, Han Y. 18β-Glycyrrhetinic acid induces immunological adjuvant activity of Th1 against Candida albicans surface mannan extract. Phytomed. 2013;20(11):951-955.
Bandyopadhyay S, Bhattacharjee A, Banerjee S, et al. Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host. Infect Immun. 2015;83(12):4476-4486.
Dinesh N, Neelagiri S, Kumar V, Singh S. Glycyrrhizic acid attenuates growth of Leishmania donovani by depleting ergosterol levels. Exp Parasitol. 2017;176:21-29.
Gupta P, Ukil A, Das PK. Bioactive component of licorice as an antileishmanial agent. Biological Activities and Action Mechanisms of Licorice Ingredients. 2017;3:147.
Nahrevanian H, Farahmand M, Aghighi Z, Assmar M, Amirkhani A. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis. Exp Parasitol. 2007;116(3):233-240.
Kropf P, Müller I, Brunson K. The Leishmaniasis Model. Meth in microbiol. 2002;32:463-492.
Coelho AC, Beverley SM, Cotrim PC. Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol Biochem Parasitol. 2003;130(2):83-90.
Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19(1):111-126.
Hefnawy A, Berg M, Dujardin J-C, De Muylder G. Exploiting knowledge on Leishmania drug resistance to support the quest for new drugs. Trends Parasitol. 2017;33(3):162-174.
Hosseini A, Jaffary F, Asghari GR, Hejazi SH, Bidabadi LS. In Vitro Effects of Turmeric and Licorice Total Extracts on L. Major Promastigotes. J of Isfahan Med School. 2012;29(169):1-11.
McClure CD, Nolan LL. Herb extracts as potential antiprotozoal agents. Int Symposium on Med and Aromatic Plants, Acta Hort. 1996;426:91-104.
Oloumi MM, Derakhshanfar A, Nikpoor A. Healing potential of liquorice root extract on dermal wounds in rats. Iranian J of Veterinar Med. 2007;1(1):147-154.
Ota H, Takashima Y, Matsumoto Y, Hayashi Y, Matsumoto Y. Pretreatment of macrophages with the combination of IFN-γ and IL-12 induces resistance to Leishmania major at the early phase of infection. J Vet Med Sci. 2008;70(6):589-593.
Ukil A, Biswas A, Das T, Das PK. 18β-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-κB. J Immunol. 2005;175(2):1161-1169.
Hussain K, Iqbal Z, Zahid Abbas R, Kasib Khan M, Kashif SM. Immunomodulatory activity of Glycyrrhiza glabra extract against mixed Eimeria infection in chickens. Int J Agric and Biol. 2017;19(4).
He X, Li X, Liu B, Xu L, Zhao H, Lu A. Down-regulation of Treg cells and up-regulation of TH1/TH2 cytokine ratio were induced by polysaccharide from Radix Glycyrrhizae in H22 hepatocarcinoma bearing mice. Molecules. 2011;16(10):8343-8352.

Keywords: Glycyrrhiza glabra; Leishmania major; glycyrrhizic acid; immunomodulation

0 (Antiprotozoal Agents)
6FO62043WK (Glycyrrhizic Acid)

Date Created: 20210924 Date Completed: 20220325 Latest Revision: 20220325

20221213

10.1111/pim.12879

34559893